Anthony Gentile
Corporate Officer/Principal bei BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
Anthony Gentile ist Direktor des Programms für klinische Operationen und Finanzen bei Biohaven Pharmaceutical Holding Co. Ltd.
Aktive Positionen von Anthony Gentile
Unternehmen | Position | Beginn |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Anthony Gentile
Eastern Connecticut State University | Undergraduate Degree |
University of Hartford | Graduate Degree |
Rensselaer Polytechnic Institute | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |